Dyne Therapeutics DYN
€ 26.60
0.75%
Quartalsbericht 2024-Q2
hinzugefügt 12.08.2024
Dyne Therapeutics Bilanz 2011-2024 | DYN
Bilanz Jährlich Dyne Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-94.2 M | -142 M | -168 M | -301 M | -14.6 M | -8.12 M | 8.07 B | 7.2 B | 6.78 B | 5.24 B | 1.15 B | 1.07 B | 192 M |
Langfristige Schulden |
22.7 M | 25.9 M | 28.7 M | - | - | - | 8.33 B | 8.78 B | 7.21 B | 7.08 B | 1.98 B | 1.39 B | 584 M |
Langfristiger Schuldenstrom |
4.72 M | 4.61 M | 3.89 M | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 42 K | 12.4 M | 8.48 B | 8.95 B | 7.42 B | 7.31 B | 2.26 B | 1.74 B | 734 M |
Kurzfristige Verbindlichkeiten |
51.1 M | 28.1 M | 28.7 M | 11 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
73.8 M | 54 M | 57.5 M | 11 M | 2.4 M | 13.1 M | 9.87 B | 11 B | 8.62 B | 8.21 B | 3.08 B | 2.03 B | 3.02 B |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | 7 M | 5 M | 29 M | 20 M | 100 M | 95 M | 5 M |
Gewinnrücklagen |
-633 M | -397 M | -228 M | -79.2 M | -19.7 M | -4.89 M | -1.85 B | -1.93 B | -686 M | -736 M | -463 M | -107 M | -4.84 B |
Vermögenswerte |
165 M | 306 M | 426 M | 353 M | 16.4 M | 8.27 M | 11.8 B | 13.1 B | 11.5 B | 11.2 B | 5.29 B | 4.54 B | 4.13 B |
Zahlungsmittel |
122 M | 172 M | 201 M | 301 M | - | - | - | - | - | - | - | - | - |
Buchwert |
91.3 M | 252 M | 368 M | 342 M | 14 M | -4.88 M | 1.9 B | 2.04 B | 2.92 B | 3.02 B | 2.21 B | 2.5 B | 1.11 B |
Gesamtes Eigenkapital |
91.3 M | 252 M | 368 M | 342 M | 14 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Dyne Therapeutics
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
20.9 M | 21.9 M | 22.7 M | 23.5 M | 24.3 M | 25.1 M | 25.9 M | 26.6 M | - | 28.1 M | 28.7 M | 29.4 M | - | - | - | 9.94 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
50.7 M | 44.2 M | 73.8 M | 53.2 M | 44.5 M | 46.7 M | 54 M | 49.9 M | - | 51.3 M | 57.5 M | 52.8 M | 14.6 M | 13.4 M | 11 M | 11 M | 11 M | 11 M | 2.4 M | 2.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-763 M | -698 M | -633 M | -566 M | -506 M | -441 M | -397 M | -358 M | - | -264 M | -228 M | -177 M | -134 M | -104 M | -79.2 M | -79.2 M | -79.2 M | -79.2 M | -19.7 M | -19.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
826 M | 522 M | 165 M | 205 M | 251 M | 289 M | 306 M | 300 M | - | 388 M | 426 M | 467 M | 467 M | 492 M | 353 M | 353 M | 353 M | 353 M | 16.4 M | 16.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
608 M | 272 M | 122 M | 130 M | 168 M | 181 M | 172 M | 145 M | - | 148 M | 201 M | 229 M | 258 M | 311 M | 301 M | 301 M | 301 M | 301 M | 14.6 M | 14.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
775 M | 478 M | 91.3 M | 152 M | 207 M | 242 M | 252 M | 250 M | - | 336 M | 368 M | 414 M | 453 M | 478 M | 342 M | 342 M | 342 M | 342 M | 14 M | 14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
775 M | 478 M | 91.3 M | 152 M | 207 M | 242 M | 252 M | 250 M | 287 M | 336 M | 368 M | 414 M | 453 M | 478 M | 342 M | 342 M | 342 M | 342 M | 14 M | 14 M | -8.46 M | -6.96 M | -4.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung